Silicon Laboratories Inc. — Form 10-Q Summary
Period clarification: The request metadata says 2020 Q3, but the supplied filing is for the quarter ended October 2, 2021 (fiscal 2021 Q3), with comparisons to the quarter ended October 3, 2020. Amounts are in U.S. dollars unless stated otherwise.
Business context and reporting period
Silicon Laboratories designs mixed-signal chips and software, with continuing operations focused on IoT, industrial automation and consumer markets. The filing reports three- and nine-month results through October 2, 2021. Its infrastructure and automotive business was sold to Skyworks Solutions on July 26, 2021; that business is presented as discontinued operations.
Key financial metrics
| Metric | Q3 2021 | Q3 2020 | Nine months 2021 | Nine months 2020 |
|---|---|---|---|---|
| Continuing-operations revenue | $184.8 million | $132.7 million | $512.2 million | $365.1 million |
| Gross profit / margin | $109.5 million / 59.2% | $75.5 million / 56.9% | $297.6 million / 58.1% | $210.9 million / 57.8% |
| Operating loss | $(9.3) million | $(23.6) million | $(35.5) million | $(88.7) million |
| Loss from continuing operations | $(19.7) million | $(26.7) million | $(63.4) million | $(94.1) million |
| Net income, including discontinued operations | $2,087.1 million | $3.2 million | $2,120.5 million | $3.6 million |
| Continuing-operations diluted loss per share | $(0.45) | $(0.61) | $(1.44) | $(2.15) |
- Growth and margins: Q3 continuing revenue rose 39.3% year over year, driven by IoT demand; unit volumes increased 31.9% and average selling prices 4.8%. Gross margin expanded 2.3 percentage points, primarily from product mix. For the first nine months, revenue grew 40.3%; volume rose 40.9% while average selling prices declined 0.2%.
- Expenses: Q3 R&D increased 23.3% to $72.7 million and SG&A rose 14.9% to $46.1 million, mainly reflecting personnel costs and, for R&D, new product development. Operating expenses totaled $118.8 million.
- Cash flow: For the first nine months, continuing-operations operating cash flow was $48.2 million versus $20.4 million a year earlier. Continuing investing cash flow was $(864.2) million, mainly reflecting net purchases of marketable securities; continuing financing cash flow was $(841.7) million, including substantial repurchases. Discontinued operations provided $2.817 billion of net cash, principally from the sale. Total cash and cash equivalents increased to $1.362 billion from $202.7 million at fiscal year-end.
- Liquidity and debt: Cash, cash equivalents and short-term investments totaled approximately $2.727 billion at October 2, 2021. Convertible debt, net, was $445.1 million, representing $535 million principal of 0.625% notes due 2025; the $400 million revolving facility was undrawn, and the company reported covenant compliance. The filing states liquidity is expected to meet requirements for at least 12 months.
- Balance sheet: Total assets were $3.640 billion and stockholders’ equity $2.648 billion. Accounts receivable was $72.6 million; inventory was $59.1 million. Management reported 35 days sales outstanding and 71 days of inventory.
Material changes and unusual items
- The $2.75 billion cash divestiture generated a reported pre-tax gain of $2.423 billion and Q3 after-tax discontinued-operations income of $2.107 billion. This transaction, rather than continuing-business profitability, accounts for nearly all reported Q3 net income.
- The company repurchased 4.0 million shares in a modified Dutch auction at $160 per share for $640.7 million, and repurchased additional shares under its existing program. Nine-month cash outflow for share repurchases was $688.4 million.
- Income taxes payable related to the divestiture were $328.0 million at quarter-end, including $320.1 million in other current liabilities. The filing also reports a $346.9 million estimated tax on the divestiture gain.
- The quarter’s tax provision and effective tax rate were affected by adoption of ASU 2019-12, which reallocated tax benefits between continuing and discontinued operations, and by a valuation allowance change related primarily to the divestiture.
- The 2022 convertible notes were fully converted or redeemed by March 22, 2021. Remaining convertible notes are due in 2025.
Outlook, commentary and risks
- Q4 fiscal 2021 outlook: Revenue of $195–$205 million; gross margin of 59.0%; operating expenses of approximately $126 million; effective tax rate of (14)%; and diluted loss per share of $(0.41) to $(0.31). Management expected R&D expense to remain relatively stable in absolute dollars and SG&A expense to increase versus Q3.
- Management attributed continuing-business improvement to stronger IoT demand and product mix, and highlighted new IoT connectivity, security, software and MCU offerings.
- Key risks include constrained foundry, assembly and test capacity, longer supplier lead times, and reliance on third-party manufacturing concentrated in Asia. COVID-19 disruption, semiconductor-industry cyclicality, pricing pressure, customer and distributor concentration, product qualification and development risks, and geopolitical or trade tensions are also identified.
- Three distributors each accounted for more than 10% of nine-month revenue; the three largest distributors together represented 59%. 87% of nine-month revenue was derived from outside the United States. The filing says no individual customer exceeded 10% of revenue.
- The company has $6.0 million par value of illiquid auction-rate securities, with contractual maturity in 2046, and says it cannot predict whether funds will become available earlier. It also describes an ongoing appeal of a Norwegian tax assessment of approximately $16.3 million; an unfavorable outcome could materially affect financial statements.
- Management reported disclosure controls were effective as of October 2, 2021, with no material change in internal control over financial reporting during the quarter.
Important facts for investors to verify
- Confirm that reported earnings and valuation analysis distinguish continuing operations from the one-time divestiture gain and related tax effects.
- Track post-sale revenue, gross margin, operating expenses and execution against Q4 guidance; the filing does not provide guidance beyond Q4 fiscal 2021.
- Assess whether supply constraints and capacity availability affect shipments, inventory, costs and customer demand.
- Review the final tax cash payments and any subsequent developments in the Norwegian tax appeal.
- Monitor convertible-note settlement and dilution exposure, share repurchases, and liquidity after the divestiture proceeds and tax payments.